Sheeva brings receipts to the discussion of scientists in the Epstein files.
Author Archives: Fancy Comma, LLC
Looking Back to Our First Year, Six Years Later
For our six year launchiversary, Sheeva recaps Fancy Comma’s first year of blog posts.
USAID’s Closure, Six Months Later: What are the impacts and who is filling the void?
Monet Wright unpacks the aftermath of USAID’s closing, six months later.
Regulatory and Manufacturing Reforms Can Improve Medication Access in the US
For people needing prescription drugs, prices are high and supplies low. Monet Wright suggests some reforms.
For better or worse, the US is charting new territory in health policy. What now?
Politics has fractured federal public health during and after COVID. Bipartisan narratives focused on the greater good can restore public trust in U.S. health initiatives.
What’s at stake with “America First” vs. multilateralism in US Climate Policy — and where do we go from here?
Monet Wright examines multilateralism vs. “America First” climate policies and impacts.
Participatory Action Research as a Research-Based Framework for Rapidly-Evolving Public Health Messaging
Participatory action research could improve public trust in science and communication during health crises.
A Science Freelancer’s Wish List of Creative Projects
Sheeva Azma seeks more creative freedom as a science marketer.
A Moment (and Music Playlist) for Science Creatives
Sheeva shares comments and a Spotify playlist celebrating science creatives.
The 1 Not-So-Weird Trick to Lower Healthcare Costs
Disincentivizing preventable patient harm in hospitals would boost the global economy by 0.7% per year.
Fancy Comma, LLC 